[ad_1]
The medical director of the National Health Service in England, Stephen Boyce, said health authorities are acting on the recommendation of the Medicines and Health Products Regulatory Agency, the country’s drug regulator.
And Boyce: "As is common with new vaccines, the agency recommended that people with a long history of allergic reactions not receive this vaccine preventively after symptoms appear in two patients, but both are on the road to recovery.".
And a British health official announced early Wednesday the first side effects of the promising vaccine.
John Ryan, Executive Director of the Independent Agency for the Regulation of Medicines and Health Products in Great Britain, said: "Last night (Tuesday) we faced two cases of allergic reaction. We know from very large clinical trials that this is not a characteristic of (the vaccine).".
Height: "But if we want to toughen our recommendations now that we have faced this. We make this recommendation immediately".
And clinical trials had shown the vaccine’s effectiveness by more than 90 percent, knowing that the body begins to build immunity against the Corona virus days after receiving its first dose.
“>
The Medicines and Health Products Regulatory Agency recommended that people with a “clear history” of allergic reactions should not receive the new Corona virus vaccine for US and German companies.
British health authorities are investigating two negative side effects that occurred on the first day of the country’s comprehensive vaccination program, which began on Tuesday.
The medical director of the National Health Service in England, Stephen Boyce, said health authorities are operating on the recommendation of the Medicines and Health Products Regulatory Agency, the country’s drug regulator.
Boyce said: “As is common with new vaccines, the agency has recommended that people with a long history of allergic reactions not receive this vaccine, preventively, after symptoms appear in two patients, but both are on the way. recovery “.
And a British health official announced early Wednesday the first side effects of the promising vaccine.
John Ryan, executive director of the Independent Medicines and Healthcare Products Regulatory Agency in Great Britain, said: “Last night (Tuesday) we had two cases of an allergic reaction. We know from very large clinical trials that this is not a characteristic ( of the vaccine) “.
He added: “But if we want to strengthen our recommendations now that we have faced this, we make that recommendation immediately.”
And clinical trials had shown the vaccine’s effectiveness by more than 90 percent, knowing that the body begins to build immunity against the Corona virus days after receiving its first dose.
[ad_2]